szmtag Clinical practice guideline: Recommendations on in-hospital treatment of patients with COVID-19 (11.01.2021)
DÄ internationalArchive1-2/2021Clinical practice guideline: Recommendations on in-hospital treatment of patients with COVID-19

Clinical Practice Guideline

Clinical practice guideline: Recommendations on in-hospital treatment of patients with COVID-19

Dtsch Arztebl Int 2021; 118: 1-7. DOI: 10.3238/arztebl.m2021.0110

Kluge, S; Janssens, U; Spinner, C D; Pfeifer, M; Marx, G; Karagiannidis , C

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

* Leitliniengruppe siehe Kasten
Klinik für Intensivmedizin, Universitätsklinikum Hamburg-Eppendorf: Prof. Dr. med. Stefan Kluge
Klinik für Innere Medizin, St.-Antonius-Hospital Eschweiler: Prof. Dr. med. Uwe Janssens
Klinikum rechts der Isar, Klinik und Poliklinik für Innere Medizin II, Technische Universität München, Fakultät für Medizin, München: PD Dr. med. Christoph D. Spinner
Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg: Prof. Dr. med. Michael Pfeifer
Klinik für Operative Intensivmedizin und Intermediate Care, Uniklinik RWTH Aachen: Prof. Dr. med. Gernot Marx
Abteilung Pneumologie, Intensiv- und Beatmungsmedizin, Lungenklinik Köln-Merheim: Prof. Dr. med. Christian Karagiannidis
1.Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C: [Recommendations for critically ill patients with COVID-19]. Medizinische Klinik, Intensivmedizin und Notfallmedizin 2020; 115: 175–7 CrossRef MEDLINE PubMed Central
2.Robert Koch-Institut: Epidemiologischer Steckbrief zu SARS-CoV-2 und COVID-19. www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief.html#doc13776792bodyText15. (last accessed on 10 December 2020).
3.Robert Koch-Institut: Aktueller Lage-/Situationsbericht des RKI zu COVID-19. www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Gesamt.html. (last accessed on 10 December 2020).
4.Guan WJ, Liang WH, Zhao Y, et al.: Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020; 55: 2000547. CrossRef MEDLINE PubMed Central
5.Cummings MJ, Baldwin MR, Abrams D, et al.: Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020; 395: 1763–70 CrossRef
6.Docherty AB, Harrison EM, Green CA, et al.: Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369: m1985 CrossRef MEDLINE PubMed Central
7.Jakob CEM, Borgmann S, Duygu F, et al.: First results of the „Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)“. Infection 2020; 1–11. doi: 10.1007/s15010–020–01499–0. Epub ahead of print CrossRef MEDLINE PubMed Central
8.Ackermann M, Verleden SE, Kuehnel M, et al.: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120–8 CrossRef MEDLINE
9.Karagiannidis C, Mostert C, Hentschker C, et al.: Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med 2020; 8: 853–62 CrossRef
10.Gross O, Moerer O, Weber M, Huber TB, Scheithauer S: COVID-19-associated nephritis: early warning for disease severity and complications? Lancet (London, England) 2020; 395: e87–e8 CrossRef
11.Frontera JA, Sabadia S, Lalchan R, et al.: A prospective study of neurologic disorders in hospitalized COVID-19 patients in New York City. Neurology 2020; 10.1212/WNL.0000000000010979. Epub ahead of print CrossRef MEDLINE
12.Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al.: Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020; 34: 101623 CrossRef MEDLINE PubMed Central
13.Hu R, Han C, Pei S, Yin M, Chen X: Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agents 2020; 56: 106051 CrossRef MEDLINE PubMed Central
14.Guan WJ, Ni ZY, Hu Y, et al.: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708–20 CrossRef MEDLINE PubMed Central
15.Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC: Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 2020; 324: 782–93 CrossRef MEDLINE
16.Antoch G, Urbach H, Mentzel HJ, Reimer P, Weber W, Wujciak D: SARS-CoV-2/COVID-19: Empfehlungen für die Radiologische Versorgung – Eine Stellungnahme der Deutschen Röntgengesellschaft (DRG) und weiterer Fachgesellschaften. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2020; 192: 418–21 CrossRef MEDLINE
17.Huang C, Wang Y, Li X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506 CrossRef
18.Rochwerg B, Einav S, Chaudhuri D, et al.: The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med 2020; 46: 2226–37 CrossRef MEDLINE PubMed Central
19.Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A: Consensus guidelines for managing the airway in patients with COVID-19: guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia 2020; 75: 785–99 CrossRef MEDLINE PubMed Central
20.Grasselli G, Tonetti T, Protti A, et al.: Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med 2020; 8: 1201–08 CrossRef
21.Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al.: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med 2020; 46: 2200–11 CrossRef MEDLINE PubMed Central
22.Deutsche Gesellschaft für Anästhesiologie & Intensivmedizin. S3-Leitlinie Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz. www.awmf.org. 2017 (last accessed on 16 December 2020).
23.Alhazzani W, Møller MH, Arabi YM, et al.: Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020; 46: 854–87 CrossRef MEDLINE PubMed Central
24.Empfehlungen des International Liaison Committee on Resuscitation (ILCOR), des Europäischen Rates für Wiederbelebung (ERC) und des Deutschen Rates für Wiederbelebung/German Resuscitation Council (GRC) zur CPR bei Patienten mit COVID-19. www.grc-org.de/ueber-uns/aktuelles (last accessed on 23 November 2020).
25.Wichmann D, Sperhake JP, Lütgehetmann M, et al.: Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med 2020; 173: 268–77 CrossRef CrossRef MEDLINE
26.Langer F, Kluge S, Klamroth R, Oldenburg J: Coagulopathy in COVID-19 and its implication for safe and efficacious thromboprophylaxis. Hamostaseologie 2020; 40: 264–9 CrossRef MEDLINE PubMed Central
27.Langford BJ, So M, Raybardhan S, et al.: Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020; 26: 1622–9 CrossRef MEDLINE
28.Simonovich VA, Burgos Pratx LD, Scibona P, et al.: A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N Engl J Med 2020: doi: 10.1056/NEJMoa2031304. Epub ahead of print CrossRef MEDLINE
29.Beigel JH, Tomashek KM, Dodd LE, et al.: Remdesivir for the treatment of covid--19—final report. N Engl J Med 2020; 383: 1813–26 CrossRef MEDLINE PubMed Central
30.Pan H, Peto R, Henao-Restrepo AM, et al.: Repurposed antiviral drugs for covid-19—interim WHO Solidarity trial results. N Engl J Med 2020. doi: 10.1056/NEJMoa2023184. Epub ahead of print CrossRef MEDLINE
31.Rochwerg B, Agoritsas T, Lamontagne F, et al.: A living WHO guideline on drugs for covid-19. BMJ 2020; 370: m3379 CrossRef MEDLINE
32.Horby P, Lim WS, Emberson JR, et al.: Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med 2020; NEJMoa2021436. doi: 10.1056/NEJMoa2021436. Epub ahead of print CrossRef MEDLINE PubMed Central
33.Sterne JAC, Murthy S, Diaz JV, et al.: Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 2020; 324: 1330–41 CrossRef MEDLINE
34.WHO: Corticosteroids for COVID-19—living guidance. 02.09.2020. www.who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1 (last accessed on 16 December 2020).
35.Nachtigall I, Lenga P, Jóźwiak K, et al.: Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study. Clin Microbiol Infect 2020; 26: 1663–9 CrossRef MEDLINE PubMed Central
36.Carfì A, Bernabei R, Landi F: Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603–5 CrossRef MEDLINE
37.Hickie I, Davenport T, Wakefield D, et al.: Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (Clinical research ed.). 2006; 333: 575 CrossRef MEDLINE PubMed Central
38.Patel NA: Pediatric COVID-19: systematic review of the literature. Am J Otolaryngol 2020; 41: 102573 CrossRef MEDLINE
39.Dutzmann J, Hartog C, Janssens U, et al.: Entscheidungen über die Zuteilung intensivmedizinischer Ressourcen im Kontext der COVID-19-Pandemie. www.divi.de/register/aktuelle-informationen (last accessed on 23 November 2020).
40.Pfeifer M, Ewig S, Voshaar T, et al.: Positionspapier zur praktischen Umsetzung der apparativen Differenzialtherapie der akuten respiratorischen Insuffizienz bei COVID-19. Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP). Pneumologie 2020; 74: 337–57 CrossRef MEDLINE PubMed Central
e1.Schälte G, Kehl F, Didion N, et al.: Besonderheiten des Atemwegsmanagements bei Patienten mit vermuteter oder gesicherter COVID-19 Erkrankung und bei Patienten ohne Infektion während der Corona-Pandemie. Empfehlungen von DGAI und BDA. Anästh Intensivmed 2020; 61: S132–S6.< /td>
e2.WHO: Clinical management of COVID-19. https://www.who.int/publications/i/item/clinical-management-of-covid-19. Version from 27.05.2020 (last accessed on 10 December 2020).